NanoViricides Inc. (NNVC)

[Ubertino]

[e-mail]

3:29 PM (8 minutes ago)

to me

The virus attaches to the newly designed small molecular mimic of the glycoprotein that’s expressed on the surface of the host cell!

EbolaCide2 now ignores the sGP [See: http://www.ncbi.nlm.nih.gov/pubmed/16977667 ]that’s released into the circulation

Same mechanism of action as all the other nanoviricides, different ligand


Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

On Aug 28, 2014, at 12:05 PM, I wrote:

Dear Gene;

I asked on iHub but got no reply - can you please explain the way the new EbolaCide removes the decoy Ebola?

Ref:
nanopatent Member Level Thursday, 08/28/14 10:14:56 AM
Re: another_voice_2 post# 97627
Post # of 97689

How do they attract the decoy? The decoy, I take it, gets the immune system all hot and bothered but does not infect any cells. So how do they get its attention and remove it? By mimicking a cell won't work as it does not go for a cell. Get my point?

I guess this is why I post on message boards and others do the inventing and accomplishments!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105737958

Me
****

My bolding and sGP URL.